These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15067696)

  • 1. A biodegradable injectable thermoplastic for localized camptothecin delivery.
    Hatefi A; Knight D; Amsden B
    J Pharm Sci; 2004 May; 93(5):1195-204. PubMed ID: 15067696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of biodegradable injectable thermoplastic oligomers.
    Amsden B; Hatefi A; Knight D; Bravo-Grimaldo E
    Biomacromolecules; 2004; 5(2):637-42. PubMed ID: 15003031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and in vitro characterization of SN-38-loaded, self-forming polymeric depots as an injectable drug delivery system.
    Manaspon C; Hongeng S; Boongird A; Nasongkla N
    J Pharm Sci; 2012 Oct; 101(10):3708-17. PubMed ID: 22778058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initiator structure influence on thermal and rheological properties of oligo(epsilon-caprolactone).
    Mikhail A; Sharifpoor S; Amsden B
    J Biomater Sci Polym Ed; 2006; 17(3):291-301. PubMed ID: 16689016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro release of a water-soluble agent from low viscosity biodegradable, injectable oligomers.
    Sharifpoor S; Amsden B
    Eur J Pharm Biopharm; 2007 Mar; 65(3):336-45. PubMed ID: 17084069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone).
    Durán N; De Oliveira AF; De Azevedo MM
    J Chemother; 2006 Oct; 18(5):473-9. PubMed ID: 17127222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable block copolymer hydrogels for sustained release of a PEGylated drug.
    Yu L; Chang GT; Zhang H; Ding JD
    Int J Pharm; 2008 Feb; 348(1-2):95-106. PubMed ID: 17825508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osmotic pressure driven protein release from viscous liquid, hydrophobic polymers based on 5-ethylene ketal ε-caprolactone: potential and mechanism.
    Babasola IO; Zhang W; Amsden BG
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):765-72. PubMed ID: 23665446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor Drugs.
    Sun Z; Duan R; Xing D; Pang X; Li Z; Chen X
    Curr Cancer Drug Targets; 2017; 17(5):445-455. PubMed ID: 28067177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(sebacic acid-co-ricinoleic acid) biodegradable injectable in situ gelling polymer.
    Shikanov A; Domb AJ
    Biomacromolecules; 2006 Jan; 7(1):288-96. PubMed ID: 16398527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable shape-memory polymers exhibiting sharp thermal transitions and controlled drug release.
    Nagahama K; Ueda Y; Ouchi T; Ohya Y
    Biomacromolecules; 2009 Jul; 10(7):1789-94. PubMed ID: 19425546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled delivery system for norethindrone based on biodegradable poly-alpha,beta-(hydroxyalkyl)-DL-aspartamide.
    Tang G; Zhu K; Chen Q
    Drug Deliv; 2002; 9(4):215-22. PubMed ID: 12511199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly-epsilon-caprolactone microspheres and nanospheres: an overview.
    Sinha VR; Bansal K; Kaushik R; Kumria R; Trehan A
    Int J Pharm; 2004 Jun; 278(1):1-23. PubMed ID: 15158945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poly(D,L-lactide-ran-epsilon-caprolactone)-poly(ethylene glycol)-poly(D,L-lactide-ran-epsilon-caprolactone) as parenteral drug-delivery systems.
    Cho H; Chung D; Jeongho A
    Biomaterials; 2004 Aug; 25(17):3733-42. PubMed ID: 15020149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticles.
    Yang L; Cui F; Cun D; Tao A; Shi K; Lin W
    Int J Pharm; 2007 Aug; 340(1-2):163-72. PubMed ID: 17482779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thermoresponsive biodegradable PEG-PCL-PEG based injectable hydrogel for pulsatile insulin delivery.
    Payyappilly S; Dhara S; Chattopadhyay S
    J Biomed Mater Res A; 2014 May; 102(5):1500-9. PubMed ID: 23681592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained interferon-gamma delivery from a photocrosslinked biodegradable elastomer.
    Gu F; Younes HM; El-Kadi AO; Neufeld RJ; Amsden BG
    J Control Release; 2005 Feb; 102(3):607-17. PubMed ID: 15681083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable injectable in situ forming drug delivery systems.
    Hatefi A; Amsden B
    J Control Release; 2002 Apr; 80(1-3):9-28. PubMed ID: 11943384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of extended release Kollidon SR mini-matrices prepared by hot-melt extrusion.
    Ozgüney I; Shuwisitkul D; Bodmeier R
    Eur J Pharm Biopharm; 2009 Sep; 73(1):140-5. PubMed ID: 19406237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.